Acute Kidney Injury (AKI), also known as acute renal failure (ARF), is a sudden episode of kidney failure or kidney damage. AKI is characterized by abrupt deterioration in kidney function, manifested by an increase in serum creatinine level with or without reduced urine output.
“DelveInsight’s, “Acute Kidney Injury Pipeline Insight, 2021,” report provides comprehensive insights about 40+ companies and 40+ pipeline drugs in Acute Kidney Injury pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Some of Acute Kidney Injury Companies are:
- Atox Bio
- AM Pharma Holding
- Quark-Pharmaceuticals
- LG Chem
- Pharming Group
- Angion Biomedica
- Elysium Health
- Sentien Biotechnologies
- Pharmazz
- Arch Biopartners
- Guard Therapeutics
- RegeneRx Biopharmaceuticals
- Cerenis Therapeutics
- And Many Others
Request for free Sample Report: https://www.delveinsight.com/sample-request/acute-kidney-injury-aki-pipeline-insight
DelveInsight’s Acute Kidney Injury report covers around 40+ products under different phases of clinical development like:
- Late stage products (Phase III)
- Mid-stage products (Phase II)
- Early-stage product (Phase I) along with the details of
- Pre-clinical and Discovery stage candidates
- Discontinued & Inactive candidates
- Route of Administration
Some of Acute Kidney Injury therapies are:
- Reltecimod
- Recombinant alkaline phosphatase
- Teprasiran
- Gemigliptin
- rhC1INH
- ANG-3777
- EH 301
- SBI 101
- Centhaquine
- Cilastatin
- RMC 035
- Timbetasin RegeneRx Biopharmaceuticals
- CER 001
- And Many Others
Request for free Sample Report: https://www.delveinsight.com/sample-request/acute-kidney-injury-aki-pipeline-insight
Current Acute Kidney Injury Treatment Scenario and Acute Kidney Injury Emerging Therapies:
- How many companies are developing Acute Kidney Injury drugs?
- How many Acute Kidney Injury drugs are developed by each company?
- How many emerging drugs are in mid-stage, and late-stage of development for the treatment of Acute Kidney Injury?
- What are the key collaborations (Industry–Industry, Industry–Academia), Mergers and acquisitions, licensing activities related to the Acute Kidney Injury therapeutics?
- What are the recent trends, drug types and novel technologies developed to overcome the limitation of existing therapies?
- What are the clinical studies going on for Acute Kidney Injury and their status?
- What are the key designations that have been granted to the emerging drugs?
Request for free Sample Report: https://www.delveinsight.com/sample-request/acute-kidney-injury-aki-pipeline-insight
Table of Contents:
Introduction
Executive Summary
Acute Kidney Injury: Overview
Pipeline Therapeutics
• Comparative Analysis
Therapeutic Assessment
Acute Kidney Injury – DelveInsight’s Analytical Perspective
In-depth Commercial Assessment
Acute Kidney Injury Collaboration Deals
Late Stage Products (Phase III)
• Comparative Analysis
Teprasiran: Quark-Pharmaceuticals
Drug profiles in the detailed report…..
Mid Stage Products (Phase II)
• Comparative Analysis
EH 301: Elysium Health
Drug profiles in the detailed report…..
Early Stage Products (Phase I)
• Comparative Analysis
Centhaquine: Pharmazz
Drug profiles in the detailed report…..
Preclinical/Discovery Stage Products
• Comparative Analysis
Timbetasin: RegeneRx Biopharmaceuticals
Drug profiles in the detailed report…..
Inactive Products
• Comparative Analysis
Acute Kidney Injury Key Companies
Acute Kidney Injury Key Products
Acute Kidney Injury- Unmet Needs
Acute Kidney Injury- Market Drivers and Barriers
Acute Kidney Injury- Future Perspectives and Conclusion
Acute Kidney Injury Analyst Views
Acute Kidney Injury Key Companies
Appendix
Request for Detailed TOC: https://www.delveinsight.com/sample-request/acute-kidney-injury-aki-pipeline-insight
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +19193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/report-store/acute-kidney-injury-aki-pipeline-insight